Detalhe da pesquisa
1.
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
J Interv Cardiol
; 2019: 7169275, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31772544
2.
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
J Behav Med
; 39(4): 687-93, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27017335
3.
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Am Heart J
; 169(3): 412-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728732
4.
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
Am Heart J
; 166(1): 134-41, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816032
5.
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study.
Psychosom Med
; 74(3): 263-70, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22434916
6.
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
Am Heart J
; 162(4): 678-84, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21982660
7.
Prior Oral Contraceptive Use and Longer Term Mortality Outcomes in Women with Suspected Ischemic Heart Disease.
J Womens Health (Larchmt)
; 30(3): 377-384, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33481672
8.
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Am Heart J
; 159(6): 987.e1-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20569710
9.
Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Psychosom Med
; 72(6): 549-55, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20410246
10.
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
J Am Heart Assoc
; 9(4): e013168, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063125
11.
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).
Am Heart J
; 157(3): 548-55, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19249427
12.
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Psychosom Med
; 71(9): 958-64, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19834049
13.
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation.
J Am Heart Assoc
; 8(12): e012406, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31165670
14.
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
J Am Coll Cardiol
; 73(6): 684-693, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765035
15.
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
J Clin Endocrinol Metab
; 93(11): 4268-75, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18728170
16.
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
J Clin Endocrinol Metab
; 93(4): 1276-84, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18182456
17.
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
J Transl Med
; 6: 11, 2008 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18331634
18.
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).
Am J Cardiol
; 102(2): 150-4, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18602512
19.
Depression, the metabolic syndrome and cardiovascular risk.
Psychosom Med
; 70(1): 40-8, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18158378
20.
Social networks and incident stroke among women with suspected myocardial ischemia.
Psychosom Med
; 70(3): 282-7, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18378868